Rongved; Pal
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rongved; Pal.The latest application filed is for "compositions and methods to disinfect, treat and prevent microbial infections".
Company Profile
0.28.53
- Rongved; Pal - Oslo NO
- Rongved; Pal - Blindern N/A NO
- Rongved; Pal - Nesoddtanken NO
- Rongved; Pal - Nesoddtangen NO
- Rongved; Pal - Nesoddtaugen NO
- Rongved, Pal - Hellvik NO
- Rongved, Pal - Nycoveien NO
- Rongved; Pal - Nesoddtanger NO
Patent Activity
| Patent | Date |
|---|---|
| Compositions And Methods To Disinfect, Treat And Prevent Microbial Infections App 20220008456 - Almas; Geir Hermod ; et al. | 2022-01-13 |
| Compositions And Methods To Disinfect, Treat And Prevent Microbial Infections App 20210352905 - Almas; Geir Hermod ; et al. | 2021-11-18 |
| Substituted Phenazines And Methods Of Treating Cancer And Bacterial Diseases App 20210292313 - RONGVED; Pal ; et al. | 2021-09-23 |
| Compounds App 20210221791 - RONGVED; Pal ; et al. | 2021-07-22 |
| Substituted phenazines and methods of treating cancer and bacterial diseases Grant 11,046,678 - Rongved , et al. June 29, 2 | 2021-06-29 |
| Compounds Grant 10,961,223 - Rongved , et al. March 30, 2 | 2021-03-30 |
| Compounds App 20200095237 - RONGVED; Pal ; et al. | 2020-03-26 |
| Compounds App 20190284167 - RONGVED; Pal ; et al. | 2019-09-19 |
| Inhibitors of metallo-beta-lactamase (MBL) comprising a zinc chelating moiety Grant 10,227,327 - Rongved , et al. | 2019-03-12 |
| Phenazine derivatives as anti-neoplastic agents and anti-infective agents Grant 9,745,273 - Doskeland , et al. August 29, 2 | 2017-08-29 |
| Compounds App 20160251320 - DOSKELAND; Stein Ove ; et al. | 2016-09-01 |
| Inhibitors of Metallo-Beta-Lactamase (MBL) Comprising a Zinc Chelating Moiety App 20160244431 - RONGVED; Pal ; et al. | 2016-08-25 |
| Peptides Grant 9,227,995 - Jacobsen , et al. January 5, 2 | 2016-01-05 |
| Compounds, compositions and use Grant 8,710,008 - Jacobsen , et al. April 29, 2 | 2014-04-29 |
| Compounds, Compositions And Use App 20120245094 - Jacobsen; Oyvind ; et al. | 2012-09-27 |
| Oral dosage form App 20110275594 - Klaveness; Jo ; et al. | 2011-11-10 |
| Peptides App 20110263479 - Jacobsen; Oyvind ; et al. | 2011-10-27 |
| Magnetic resonance imaging method and compounds for use in the method Grant 7,966,056 - Rongved , et al. June 21, 2 | 2011-06-21 |
| Topical Compositions App 20110123463 - Klaveness; Jo ; et al. | 2011-05-26 |
| Contrast agents Grant 7,892,522 - Johnson , et al. February 22, 2 | 2011-02-22 |
| Oral Dosage Form App 20100291206 - Klaveness; Jo ; et al. | 2010-11-18 |
| Treatment Of Insulin Resistance And Disorders Associated Therewith App 20100137266 - Kase; Eili Tranheim ; et al. | 2010-06-03 |
| Omega 3 App 20090221705 - Rongved; Pal ; et al. | 2009-09-03 |
| Use Of Particulate Contrast Agents In Diagnostic Imaging For Studying Physiological Paramaters App 20090191131 - Fossheim; Sigrid Lise ; et al. | 2009-07-30 |
| Omega 3 App 20070213298 - Rongved; Pal ; et al. | 2007-09-13 |
| Metal complex compounds Grant 7,198,776 - Klaveness , et al. April 3, 2 | 2007-04-03 |
| Separation processes App 20070036722 - Rongved; Pal ; et al. | 2007-02-15 |
| Contrast agents App 20070014731 - Klaveness; Jo ; et al. | 2007-01-18 |
| Contrast agents App 20070003485 - Klaveness; Jo ; et al. | 2007-01-04 |
| Magnetic resonance imaging method and compounds for use in the method App 20060235292 - Rongved; Pal ; et al. | 2006-10-19 |
| Light imaging contrast agents Grant 7,014,839 - Klaveness , et al. March 21, 2 | 2006-03-21 |
| Contrast agents App 20050232865 - Klaveness, Jo ; et al. | 2005-10-20 |
| Contrast agents App 20050201942 - Dugstad, Harald ; et al. | 2005-09-15 |
| Contrast agents App 20050196342 - Klaveness, Jo ; et al. | 2005-09-08 |
| Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters App 20050136002 - Fossheim, Sigrid Lise ; et al. | 2005-06-23 |
| Contrast agents App 20050118104 - Ostensen, Jonny ; et al. | 2005-06-02 |
| Metal complex compounds App 20050090653 - Klaveness, Jo ; et al. | 2005-04-28 |
| Contrast agents App 20050031543 - Klaveness, Jo ; et al. | 2005-02-10 |
| Diagnostic/therapeutic agents App 20050002865 - Klaveness, Jo ; et al. | 2005-01-06 |
| Ultrasound imaging App 20040230122 - Eriksen, Morten ; et al. | 2004-11-18 |
| Contrast agents App 20040146462 - Eriksen, Morten ; et al. | 2004-07-29 |
| Contrast Agents App 20040141921 - Ostensen, Jonny ; et al. | 2004-07-22 |
| Diagnostic/therapeutic agents App 20040141922 - Klaveness, Jo ; et al. | 2004-07-22 |
| Contrast agents App 20040131548 - Klaveness, Jo ; et al. | 2004-07-08 |
| Contrast agents App 20040131549 - Klaveness, Jo ; et al. | 2004-07-08 |
| Methods of photoacoustic imaging Grant 6,662,040 - Henrichs , et al. December 9, 2 | 2003-12-09 |
| Contrast agents App 20030202942 - Dugstad, Harald ; et al. | 2003-10-30 |
| Light imaging contrast agents App 20030157021 - Klaveness, Jo ; et al. | 2003-08-21 |
| Separation processes App 20030104359 - Cuthbertson, Alan ; et al. | 2003-06-05 |
| Contrast agents App 20030059373 - Klaveness, Jo ; et al. | 2003-03-27 |
| Contrast agents App 20030031629 - Klaveness, Jo ; et al. | 2003-02-13 |
| Contrast agents App 20020172643 - Klaveness, Jo ; et al. | 2002-11-21 |
| Contrast agents App 20020106328 - Johnson, David ; et al. | 2002-08-08 |
| Diagnostic/therapeutic agents App 20020102215 - Klaveness, Jo ; et al. | 2002-08-01 |
| Diagnostic/therapeutic agents App 20020102217 - Klaveness, Jo ; et al. | 2002-08-01 |
| Method App 20020090341 - Watson, Alan David ; et al. | 2002-07-11 |
| Light imaging contrast agents App 20010022963 - Klaveness, Jo ; et al. | 2001-09-20 |
| Contrast agents App 20010019710 - Berg, Arne ; et al. | 2001-09-06 |
| Contrast agents App 20010010811 - Dugstad, Harald ; et al. | 2001-08-02 |
| Contrast Agents App 20010002993 - OSTENSEN, JONNY ; et al. | 2001-06-07 |
| Microparticulate microbubble-generating contrast agents Grant 5,827,502 - Klaveness , et al. October 27, 1 | 1998-10-27 |
| Microbubble-based contrast agents with crosslinked and reduced proteinaceous shells Grant 5,718,884 - Klaveness , et al. February 17, 1 | 1998-02-17 |
| Contrast medium for magnetic resonance imaging using physiologically tolerable manganese compound Grant 5,716,598 - Golman , et al. February 10, 1 | 1998-02-10 |
| Liposomes Grant 5,676,928 - Klaveness , et al. October 14, 1 | 1997-10-14 |
| Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons Grant 5,674,468 - Klaveness , et al. October 7, 1 | 1997-10-07 |
| Microbubble-generating contrast agents for ultrasound and magnetic resonance imaging Grant 5,558,856 - Klaveness , et al. September 24, 1 | 1996-09-24 |
| Contrast agents Grant 5,536,490 - Klaveness , et al. July 16, 1 | 1996-07-16 |
| Aminopolycarboxylic acids and derivatives thereof Grant 5,531,978 - Berg , et al. July 2, 1 | 1996-07-02 |
| Contrast agents Grant 5,529,766 - Klaveness , et al. June 25, 1 | 1996-06-25 |
| Multinuclear complexes for X-ray imaging Grant 5,458,869 - Berg , et al. October 17, 1 | 1995-10-17 |
| Aminopolycarboxylic acids and derivatives thereof for magnetic resonance imaging Grant 5,419,893 - Berg , et al. May 30, 1 | 1995-05-30 |
| Paramagnetic compounds Grant 5,208,324 - Klaveness , et al. May 4, 1 | 1993-05-04 |
| Aminopolycarboxylic acids and derivatives thereof Grant 5,198,208 - Berg , et al. March 30, 1 | 1993-03-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 